» Articles » PMID: 37715213

Implementation of Risk Stratification Within Bowel Cancer Screening: a Community Jury Study Exploring Public Acceptability and Communication Needs

Overview
Publisher Biomed Central
Specialty Public Health
Date 2023 Sep 15
PMID 37715213
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Population-based cancer screening programmes are shifting away from age and/or sex-based screening criteria towards a risk-stratified approach. Any such changes must be acceptable to the public and communicated effectively. We aimed to explore the social and ethical considerations of implementing risk stratification at three different stages of the bowel cancer screening programme and to understand public requirements for communication.

Methods: We conducted two pairs of community juries, addressing risk stratification for screening eligibility or thresholds for referral to colonoscopy and screening interval. Using screening test results (where applicable), and lifestyle and genetic risk scores were suggested as potential stratification strategies. After being informed about the topic through a series of presentations and discussions including screening principles, ethical considerations and how risk stratification could be incorporated, participants deliberated over the research questions. They then reported their final verdicts on the acceptability of risk-stratified screening and what information should be shared about their preferred screening strategy. Transcripts were analysed using codebook thematic analysis.

Results: Risk stratification of bowel cancer screening was acceptable to the informed public. Using data within the current system (age, sex and screening results) was considered an obvious next step and collecting additional data for lifestyle and/or genetic risk assessment was also preferable to age-based screening. Participants acknowledged benefits to individuals and health services, as well as articulating concerns for people with low cancer risk, potential public misconceptions and additional complexity for the system. The need for clear and effective communication about changes to the screening programme and individual risk feedback was highlighted, including making a distinction between information that should be shared with everyone by default and additional details that are available elsewhere.

Conclusions: From the perspective of public acceptability, risk stratification using current data could be implemented immediately, ahead of more complex strategies. Collecting additional data for lifestyle and/or genetic risk assessment was also considered acceptable but the practicalities of collecting such data and how the programme would be communicated require careful consideration.

Citing Articles

Societal views on using risk-based innovations to inform cancer screening and referral policies: findings from three community juries.

Dennison R, Clune R, Tung J, John S, Moorthie S, Waller J BMC Public Health. 2025; 25(1):801.

PMID: 40016715 PMC: 11869612. DOI: 10.1186/s12889-025-21996-x.


A systems based qualitative analysis exploring the potential to implement risk stratified bowel cancer screening in England.

Moorthie S, Taylor L, Dennison R, Usher-Smith J BMC Health Serv Res. 2025; 25(1):226.

PMID: 39930493 PMC: 11812230. DOI: 10.1186/s12913-025-12381-w.


Public acceptability and anticipated uptake of risk-stratified bowel cancer screening in the UK: An online survey.

Taylor L, Dennison R, Usher-Smith J Prev Med Rep. 2024; 48:102927.

PMID: 39634284 PMC: 11614824. DOI: 10.1016/j.pmedr.2024.102927.


Understanding the Preferences and Considerations of the Public Towards Risk-Stratified Screening for Colorectal Cancer: Insights From Think-Aloud Interviews Based on a Discrete Choice Experiment.

Dennison R, Clune R, Morris S, Thomas C, Usher-Smith J Health Expect. 2024; 27(4):e14153.

PMID: 39030943 PMC: 11258464. DOI: 10.1111/hex.14153.

References
1.
Schreuders E, Ruco A, Rabeneck L, Schoen R, Sung J, Young G . Colorectal cancer screening: a global overview of existing programmes. Gut. 2015; 64(10):1637-49. DOI: 10.1136/gutjnl-2014-309086. View

2.
Lin J, Piper M, Perdue L, Rutter C, Webber E, OConnor E . Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016; 315(23):2576-94. DOI: 10.1001/jama.2016.3332. View

3.
Lansdorp-Vogelaar I, Meester R, de Jonge L, Buron A, Haug U, Senore C . Risk-stratified strategies in population screening for colorectal cancer. Int J Cancer. 2021; 150(3):397-405. PMC: 9293115. DOI: 10.1002/ijc.33784. View

4.
Hull M, Rees C, Sharp L, Koo S . A risk-stratified approach to colorectal cancer prevention and diagnosis. Nat Rev Gastroenterol Hepatol. 2020; 17(12):773-780. PMC: 7562765. DOI: 10.1038/s41575-020-00368-3. View

5.
Kortlever T, van der Vlugt M, Dekker E, Bossuyt P . Individualized faecal immunochemical test cut-off based on age and sex in colorectal cancer screening. Prev Med Rep. 2021; 23:101447. PMC: 8209662. DOI: 10.1016/j.pmedr.2021.101447. View